282 related articles for article (PubMed ID: 19938416)
21. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
Jacobs JW; Blaauw AA; Dijkmans BA; van Riel PL; Bijlsma JW
Ned Tijdschr Geneeskd; 2000 Jan; 144(5):211-6. PubMed ID: 10682647
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Tijhuis GJ; van de Putte LB; Breedveld FC
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
[TBL] [Abstract][Full Text] [Related]
24. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of early rheumatoid arthritis.
Brown AN
J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics in rheumatoid arthritis.
Ranganathan P
Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
[TBL] [Abstract][Full Text] [Related]
28. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Sokka T; Pincus T
J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
[TBL] [Abstract][Full Text] [Related]
29. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
30. [Rituximab (MabThera)--a new biological medicine in rheumatoid arthritis therapy].
Nemec P
Vnitr Lek; 2007 Nov; 53(11):1199-210. PubMed ID: 18277630
[TBL] [Abstract][Full Text] [Related]
31. Rituximab therapy in rheumatoid arthritis in daily practice.
Assous N; Gossec L; Dieudé P; Meyer O; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2008 Jan; 35(1):31-4. PubMed ID: 18176989
[TBL] [Abstract][Full Text] [Related]
32. Early rheumatoid arthritis.
Mitchell KL; Pisetsky DS
Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
[TBL] [Abstract][Full Text] [Related]
33. [Practice guideline 'Diagnosis and treatment of rheumatoid arthritis'].
Schipper LG; Hoekstra M; Vliet Vlieland TP; Jansen TL; Lems WF; van Riel P;
Ned Tijdschr Geneeskd; 2009; 153():A944. PubMed ID: 20051161
[TBL] [Abstract][Full Text] [Related]
34. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
[TBL] [Abstract][Full Text] [Related]
35. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
Sanders S; Geraci SA
J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease in rheumatoid arthritis: a step forward.
Myasoedova E; Gabriel SE
Curr Opin Rheumatol; 2010 May; 22(3):342-7. PubMed ID: 20164773
[TBL] [Abstract][Full Text] [Related]
38. [Disease modifying anti-rheumatic drugs(DMARDs)].
Matsuda Y
Nihon Rinsho; 1999 Feb; 57(2):439-44. PubMed ID: 10078020
[TBL] [Abstract][Full Text] [Related]
39. Perspectives on rheumatoid arthritis for the orthopedic surgeon: overview of early diagnosis and the tumor necrosis factor antagonists.
Keith MP
Am J Orthop (Belle Mead NJ); 2011 Sep; 40(9):E193-5. PubMed ID: 22022685
[TBL] [Abstract][Full Text] [Related]
40. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
Swierkot J; Madej M
Pol Merkur Lekarski; 2011 Apr; 30(178):289-94. PubMed ID: 21595177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]